Keyphrases
Papillary Thyroid Carcinoma
100%
Senescence
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Migration Invasion
100%
Focal Adhesion Kinase
100%
Thyroid Carcinoma Cells
100%
Phosphatidylinositol 3-kinase/Akt Signaling
100%
ERK2
22%
BCPAP Cells
22%
Therapeutic Target
11%
Knockdown
11%
Small Interfering RNA (siRNA)
11%
Tumorigenesis
11%
Multiple Signaling Pathways
11%
MRNA Level
11%
Endocrine Malignancies
11%
Metastasis
11%
Invasiveness
11%
New Evidence
11%
AKT Pathway
11%
Role in Cancer
11%
Nuclear Morphology
11%
Cancer Pathogenesis
11%
Plasminogen
11%
Carcinoma Cell Lines
11%
Hyperphosphorylation
11%
Decreased Activity
11%
Genetic mutation
11%
Migration Rate
11%
β-Galactosidase (β-Gal)
11%
Senescence-associated
11%
Proliferation Rate
11%
U0126
11%
ERK Inhibitor
11%
Thyroid Malignancy
11%
MEK-ERK
11%
Invasion Rate
11%
Extracellular Matrix Invasion
11%
BCPAP
11%
Medicine and Dentistry
Downregulation
100%
Urokinase Receptor
100%
Phosphoinositide 3-Kinase
100%
Focal Adhesion Kinase
100%
Akt Signaling
100%
Papillary Thyroid Carcinoma Cell
100%
Janus Kinase 1
100%
Papillary Thyroid Cancer
33%
Cancer
22%
Mitogen Activated Protein Kinase 3
22%
Cell Signaling Pathway
22%
Malignant Neoplasm
11%
Carcinogenesis
11%
Supplementation
11%
Hyperphosphorylation
11%
Extracellular Matrix
11%
Metastatic Carcinoma
11%
Gene Mutation
11%
Small Interfering RNA
11%
U0126
11%
Plasminogen
11%
Thyroid Papillary Carcinoma Cell Line
11%
Galactosidase
11%
Pharmacology, Toxicology and Pharmaceutical Science
Thyroid Papillary Carcinoma
100%
Phosphatidylinositol 3 Kinase
100%
Urokinase Receptor
100%
Focal Adhesion Kinase
100%
Janus Kinase 1
100%
Mitogen Activated Protein Kinase 3
22%
Malignant Neoplasm
11%
Small Interfering RNA
11%
Carcinogenesis
11%
Plasminogen
11%
Galactosidase
11%
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
11%